FloridaAttorney General
Ashley Moody
April 1, 2022

Florida is Headed to Trial with Walgreens Following Commitments of More Than $3 Billion from Other Pharmaceutical Companies to Help Abate Opioid Crisis

TALLAHASSEE, Fla.—Following more than $3 billion in recoveries from defendants in Florida’s historic opioid litigation, one remains—Walgreens. Attorney General Ashley Moody today announced that the State of Florida will be in trial next week to hold Walgreens accountable for its role in helping create and fuel the deadly opioid crisis devastating Florida families and draining taxpayer-funded resources.

Attorney General Ashley Moody said, “I am encouraged that all the other defendants in our historic opioid litigation stepped up, and we are recovering more than $3 billion to help Florida address the devastation caused by the opioid epidemic. It’s time for Walgreens to face accountability for their part in fueling the opioid crisis, and my team is prepared to vigorously try our strong case against them.”  

Florida’s case to hold Walgreens responsible for the pharmaceutical company’s role in the opioid crisis is set for jury trial on April 5. The case will be heard in New Port Richey, with jury selection in front of Judge Kimberly Sharpe Byrd. After jury selection, opening statements are likely to occur on or about April 11.

In court filings, the State highlights concerning evidence surrounding Walgreens’s dispensing and distribution of opioids in Florida. According to the filings, “a Walgreens drug distribution center sold 2.2 million tablets to a single Walgreens’ pharmacy in tiny Hudson, a roughly six-month supply for each of its 12,000 residents… In some cases, Walgreens increased orders as much as 600% in the space of just two years, including, for example, supplying a town of 3,000 with 285,800 orders of oxycodone in a one-month period.”

The Office of the Attorney General will outline additional facts and figures concerning Walgreens’s role in creating and fueling the deadly opioid crisis during next week’s trial.

Attorney General Moody recently announced the securement of more than $870 million for opioid abatement from former defendants in the State’s case: CVS Health Corporation, CVS Pharmacy, Inc., Teva Pharmaceuticals Industries Ltd. and Allergan PLC. Additionally, Attorney General Moody announced the finalization of the State’s agreement with Endo Health Solutions.

For more information about this massive securement, click here.

The recent securements follow several other, earlier Florida negotiations. In July 2021, Attorney General Moody announced a multibillion-dollar nationwide settlement with McKesson Corp., Cardinal Health, Inc., AmerisourceBergen Corp., and Johnson & Johnson, Inc. Florida will receive more than $1.6 billion, which must be used for remediation. Florida finalized a settlement with McKinsey & Company for $40 million in February 2021.

The OAG has set up an online portal for local governments to sign on to the various opioid-related settlements. To learn more, click here.

Share this story!

Subscribe
Notify of
guest

This site uses User Verification plugin to reduce spam. See how your comment data is processed.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Mark Tomes
Mark Tomes
4 months ago

Next should be the doctors who prescribed all that medication, knowing that people were abusing it.

1
0
Would love your thoughts, please comment.x
()
x